LD-2 disclosure · 3rd Quarter - Report
ARUP LABORATORIES, INC.
Client
- Name
- ARUP LABORATORIES, INC.
- Description
- Diagnostic testing laboratory
- Location
- Utah · United States of America
Registrant
- Description
- Government Relations Consultant
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesBudget/Appropriations
Monitor the following: H.R.4368/S.2131, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2024, FDA regulatory issues regarding Diagnostic Testing S.2624, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Laboratory capacity related issues Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues
LobbyistsJENNIFER LATOURETTE · ms LESLEE KOCH GILBERT · MATT HENKEN
Health Issues
H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues FDA regulation, Laboratory Testing related issues H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Monitor the following: Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Clinical Laboratory Improvement Amendments (CLIA), generally
LobbyistsMATT HENKEN
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medical/Disease Research/Clinical Labs
H.R.3248, Diagnostic Lab Testing Transparency Act, Laboratory Testing related issues H.R.3561, PATIENT Act of 2023, Laboratory Testing related issues H.R.5378, The Lower Cost More Transparency Act, Laboratory Testing payment related issues FDA regulation, Laboratory Testing related issues H.R.2369, VALID Act of 2023, Diagnostic Lab Testing Pandemic All Hazards Preparedness Act, generally Monitor the following: Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Clinical Laboratory Improvement Amendments (CLIA), generally